Kenvue (French Wikipedia)
Analysis of information sources in references of the Wikipedia article "Kenvue" in French language version.
Last modified:
Ref.Un. Ref.Website
Global rank
French rank
low place
low place
7th place
25th place
1,433rd place
2,844th place
101st place
309th place
2,543rd place
4,367th place
1st place
2nd place
38th place
87th place
118th place
292nd place
546th place
2,421st place
apnews.com (Global: 101st place; French: 309th place)
- (en) Michelle Chapman et Tom Murphy, « Johnson & Johnson to split into two, aim for faster growth », sur Associated Press, (consulté le )
- « J&J's Kenvue consumer health business prepares for stock IPO », Associated Press, (lire en ligne, consulté le )
axios.com (Global: 1,139th place; French: 2,546th place)
- Dan Primack, « J&J's Kenvue rallies out of the gate following IPO », Axios, (lire en ligne, consulté le )
barrons.com (Global: 2,543rd place; French: 4,367th place)
- (en) Josh Nathan-Kazis, « Kenvue Stock Jumps in IPO of Former J&J Consumer-Health Business », Barron's, Dow Jones & Company (consulté le )
bloomberg.com (Global: 118th place; French: 292nd place)
- (en) Bailey Lipschultz, « Tylenol Maker Kenvue Goes From Sure Bet to Question Mark After Year's Biggest IPO », sur Bloomberg.com, , N.PAG
- Drew Singer, « Maker of Tylenol, Band-Aid climbs in debut after biggest U.S. IPO since 2021 », Bloomberg News, (lire en ligne, consulté le )
cnbc.com (Global: 303rd place; French: 682nd place)
- Annika Kim Constantino, « Kenvue CEO looks to brand, product innovation to drive growth after IPO », CNBC, (lire en ligne, consulté le )
cnn.com (Global: 36th place; French: 126th place)
- Nathaniel Meyersohn, « Band-Aids and Tylenol will have a new name on their packages », CNN Business, (lire en ligne, consulté le )
ebscohost.com (Global: 1,433rd place; French: 2,844th place)
search.ebscohost.com
- (en) « Kenvue Showcases Tylenol Precise Cream, First Launch Since IPO », MMR, vol. 40, no 10, , p. 18 (lire en ligne)
- (en) Michael Altman, Atalay Atasu et Evren Özkaya, « How Kenvue De-Risked Its Supply Chain », Harvard Business Review Digital Articles, , p. 1–8 (lire en ligne)
ft.com (Global: 193rd place; French: 392nd place)
- Nicholas Megaw, « Johnson & Johnson consumer arm's shares jump in biggest U.S. IPO since 2021 », Financial Times, (lire en ligne, consulté le )
kenvue.com (Global: low place; French: low place)
- (en) « Our brands », Kenvue (consulté le )
nytimes.com (Global: 7th place; French: 25th place)
- Rebecca Robbins et Michael J. de la Merced, « Johnson & Johnson, iconic company under pressure, plans to split in two », The New York Times, (lire en ligne, consulté le )
- Andrew Ross Sorkin, « Pfizer said to be closing in on deal for Wyeth », The New York Times, (lire en ligne, consulté le )
- Stephanie Saul, « Johnson & Johnson buys Pfizer unit for $16.6 billion », The New York Times, (lire en ligne, consulté le )
- Andrew Ross Sorkin et Duff Wilson, « Pfizer to acquire Wyeth for $68 billion », The New York Times, (lire en ligne, consulté le )
- (en) Lauren Hirsch et Rebecca Robbins, « Kimberly-Clark Agrees to Buy Kenvue, Maker of Tylenol, for $40 Billion », The New York Times, (consulté le )
prnewswire.com (Global: 546th place; French: 2,421st place)
reuters.com (Global: 38th place; French: 87th place)
- Jessica Hall et Lewis Krauskopf, « Pfizer to buy Wyeth for $68 billion », Reuters, (lire en ligne, consulté le )
- (en) Bhanvi Satija, « J&J's consumer health unit Kenvue files for IPO, moving closer to spin-off », sur Reuters, (consulté le )
- Manya Saini, « J&J's Kenvue eyes $47 billion valuation in biggest U.S. IPO since 2021 », Reuters, (lire en ligne, consulté le )
sec.gov (Global: 617th place; French: 1,900th place)
- (en) « Form S-1, Amendment No. 4 (Kenvue, Inc.) » [archive du ], U.S. Securities and Exchange Commission, (consulté le ) : « "We were incorporated in Delaware on February 23, 2022 in connection with the Separation and were formed to ultimately hold, directly or indirectly, and conduct certain operational activities in anticipation of the planned separation of, the Consumer Health Business. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson and all of our outstanding shares of common stock are owned by Johnson & Johnson. Our principal executive offices are located [in] Skillman, NJ 08558." »
- (en) « Form S-1 (JNTL, Inc.) » [archive du ], U.S. Securities and Exchange Commission, (consulté le )
web.archive.org (Global: 1st place; French: 2nd place)
- (en) « Form S-1, Amendment No. 4 (Kenvue, Inc.) » [archive du ], U.S. Securities and Exchange Commission, (consulté le ) : « "We were incorporated in Delaware on February 23, 2022 in connection with the Separation and were formed to ultimately hold, directly or indirectly, and conduct certain operational activities in anticipation of the planned separation of, the Consumer Health Business. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson and all of our outstanding shares of common stock are owned by Johnson & Johnson. Our principal executive offices are located [in] Skillman, NJ 08558." »
- (en) « Form S-1 (JNTL, Inc.) » [archive du ], U.S. Securities and Exchange Commission, (consulté le )